CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

93 hedge funds and large institutions have $132M invested in Cascadian Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$513K
Puts
$168K
Net Calls
Net Calls Change

Top Buyers

1 +$5.41M
2 +$2.7M
3 +$1.84M
4
DS
DRW Securities
Illinois
+$1.14M
5
ARTA
A.R.T. Advisors
New York
+$864K

Top Sellers

1 -$3.08M
2 -$2.87M
3 -$2.85M
4
EC
EcoR1 Capital
California
-$2.58M
5
QF
QVT Financial
New York
-$1.68M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$41.7M
2
$15.3M
3
$9.14M
4
$8.16M
5
$7.58M
6
$7.29M
7
$6.19M
8
$5.17M
9
$3.6M
10
$2.46M
11
$2.27M
12
$1.84M
13
$1.38M
14
$1.14M
15
$1.08M
16
$1.02M
17
$960K
18
$864K
19
$847K
20
$729K
21
$722K
22
$722K
23
$702K
24
$666K
25
$666K